NASDAQ · HAO
Haoxi Health Technology Limited financials
$2.75−4.84%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Jun 30 | FY24 Jun 30 |
|---|---|---|
| Revenue | $32.8M | $48.5M |
| Gross profit | $927.8K | $2.8M |
| Gross margin | 2.8% | 5.7% |
| Operating income | -$2.0M | $1.7M |
| Net income | $3.9M | $1.3M |
| Net margin | 11.8% | 2.7% |
| Diluted EPS | $3379.20 | $2713.60 |
| EBITDA | -$1.7M | $1.7M |
| Operating cash flow | -$3.4M | -$747.6K |
| Free cash flow | -$3.4M | -$802.9K |
| Diluted shares | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Jun 30 |
|---|---|---|
| Cash & equivalents | $8.6M | $6.7M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $1.9M | $1.2M |
| Total assets | $21.6M | $15.5M |
| Total liabilities | $4.2M | $4.2M |
| Shareholders' equity | $17.4M | $11.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology